Vertex Pharmaceuticals | VRTX - Los Ingresos Por Intereses

Precio De Mercado
423.24
Cambio Diario
-6.90 -1.60%
Mensual
-4.50%
Anual
-16.93%
Q2 Expectativa
421.08




Los Ingresos Por Intereses Cambio Fecha
AbbVie USD 59M 13M 2025-12
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Arrowhead Research USD 9.05M 1.97M 2025-09
Biogen USD 37.2M 5.6M 2025-12
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Gilead Sciences USD 95M 7M 2025-12
Incyte USD 30.75M 3.97M 2025-12
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.14 237M 2026-03
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09